{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T12:15:57Z","timestamp":1794399357059,"version":"4.9.0"},"publisher-location":"Boston, MA","reference-count":228,"publisher":"Springer US","isbn-type":[{"value":"9781461285373","type":"print"},{"value":"9781461312611","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1996]]},"DOI":"10.1007\/978-1-4613-1261-1_10","type":"book-chapter","created":{"date-parts":[[2011,10,8]],"date-time":"2011-10-08T01:15:45Z","timestamp":1318036545000},"page":"207-259","source":"Crossref","is-referenced-by-count":2,"title":["Autologous bone marrow transplantation for leukemia and lymphoma"],"prefix":"10.1007","author":[{"given":"Koen","family":"van Besien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"Suppl 4","key":"10_CR1","first-page":"22","volume":"28","author":"E Frei III","year":"1991","unstructured":"Frei E III (1991). The modulation of alkylating agents. Semin Hematol 28 (Suppl 4):22.","journal-title":"Semin Hematol"},{"key":"10_CR2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00685328","volume":"33","author":"E Frei III","year":"1993","unstructured":"Frei E III, Holden SA, Gonin R, Waxman DJ, Teicher BA (1993). Antitumor alkylatingagents: in vitro cross-resistance and collateral sensitivity studies. Cancer Chemother Pharmacol 33:113.","journal-title":"Cancer Chemother Pharmacol"},{"key":"10_CR3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0002-9343(80)90472-6","volume":"69","author":"E Frei III","year":"1980","unstructured":"Frei E III, Canellos GP (1980). Dose: a critical factor in cancer chemotherapy. Am J Med 69:585.","journal-title":"Am J Med"},{"key":"10_CR4","first-page":"607","volume-title":"Bone Marrow Transplantation","author":"GD Long","year":"1994","unstructured":"Long GD, Blume KG (1994). Allogeneic bone marrow transplantation for acute myeloid leukemia. In Forman SJ, Blume KG, Thomas ED (eds), Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, pp. 607."},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM199201163260303","volume":"326","author":"E Berman","year":"1992","unstructured":"Berman E, Little C, Gee T, O\u2019Reilly R, Clarkson B (1992). Reasons that ptients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation. N Engl J Med 326:156.","journal-title":"N Engl J Med"},{"key":"10_CR6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1182\/blood.V80.4.1090.bloodjournal8041090","volume":"80","author":"JC Biggs","year":"1992","unstructured":"Biggs JC, Horowitz MM, Gale RP, Ash RC, Atkinson K, Helbig W, Jacobsen N, Phillips GL, Rimm AA, Ringd\u00e9n O, Rozman C, Sobocinski KA, Veum JA, Bortin MM (1992). Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy. Blood 80:1090.","journal-title":"Blood"},{"key":"10_CR7","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.1992.10.11.1723","volume":"10","author":"RA Clift","year":"1992","unstructured":"Clift RA, Buckner CD, Appelbaum FR, Schoch G, Petersen FB, Bensinger WI, Sanders J, Sullivan KM, Storb R, Singer J, Hansen JA, Thomas ED (1992). Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia. J Clin Oncol 10:1723.","journal-title":"J Clin Oncol"},{"key":"10_CR8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1182\/blood.V57.3.421.421","volume":"57","author":"A Fefer","year":"1981","unstructured":"Fefer A, Cheever MA, Thomas ED, et al. (1981). Bone marrow transplantation for refractory acute leukemia in 34 patients with identical twins. Blood 57:421.","journal-title":"Blood"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(79)90943-7","volume":"i","author":"KA Dicke","year":"1979","unstructured":"Dicke KA, Spitzer G, Peters L, et al. (1979). Autologous bone marrow transplantation in relapsed adult acute leukemia. Lancet i:514.","journal-title":"Lancet"},{"key":"10_CR10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0145-2126(85)90063-3","volume":"9","author":"GP Meloni","year":"1985","unstructured":"Meloni GP, Fabritis G, dePapa G, Amadori S, Pulsoni A, Simone F, Mandelli F (1985). Cryopreserved autologous bone marrow infusion following high dose chemotherapy in patients with acute myeloblasts leukemia in first relapse. Leuk Res 9:407.","journal-title":"Leuk Res"},{"key":"10_CR11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/1097-0142(19900815)66:4<619::AID-CNCR2820660403>3.0.CO;2-Z","volume":"66","author":"JA Spinolo","year":"1990","unstructured":"Spinolo JA, Dicke KA, Horwitz LJ, Jagannath S, McCredie K, Estey E, Kantarjian H, Zander AR, Keating M, Spitzer G (1990). High-dose chemotherapy and unpurged autologous bone marrow transplantation for acute leukemia in second or subsequent remission. Cancer 66:619.","journal-title":"Cancer"},{"key":"10_CR12","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1200\/JCO.1991.9.10.1840","volume":"9","author":"R Chopra","year":"1991","unstructured":"Chopra R, Goldstone AH, McMillan AK, Powles R, Smith AG, Prentice HG, Reid C, Marcus R, Bell A, Milligan D, McCarthy D, Morgenstern G, Barnard D (1991). Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan\/cyclophosphamide and unpurged marrow: The British Autograft Group experience. J Clin Oncol 9:1840.","journal-title":"J Clin Oncol"},{"key":"10_CR13","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood.V74.3.1159.1159","volume":"74","author":"C Rosenfeld","year":"1989","unstructured":"Rosenfeld C, Shadduck RK, Przepiorka D, Mangan KF, Colvin M (1989). Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrows for acute nonlymphocytic leukemia in late remission or early relapse. Blood 74:1159.","journal-title":"Blood"},{"key":"10_CR14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0609.1989.tb01468.x","volume":"42","author":"G Meloni","year":"1989","unstructured":"Meloni G, de Fabritis P, Pulsoni A, Sandrelli A, Simone F, Mandelli F (1989). Acute myelogenous leukemia in first relapse treated with two consecutive autologous bone marrow transplantations: a pilot study. Eur J Haematol 42:441.","journal-title":"Eur J Haematol"},{"key":"10_CR15","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1182\/blood.V75.12.2282.2282","volume":"75","author":"G Meloni","year":"1990","unstructured":"Meloni G, De Fabritiis P, Petti MC, Mandelli F (1990). BVAC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remission. Blood 75:2282.","journal-title":"Blood"},{"issue":"Sl","key":"10_CR16","first-page":"202a","volume":"84","author":"G Meloni","year":"1994","unstructured":"Meloni G, Vignetti M, Avvisati G, Andrizzi C, Capria S, Orsini E, Simone F, Todisco E, Vegna ML, Mandelli F (1994). Autologous BMT in 199 AML patients in CR: 10 year experience at the hematology section of the university \u2018la Sapienza\u2019 of Rome. Blood 84 S1:202a.","journal-title":"Blood"},{"key":"10_CR17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood.V81.2.311.311","volume":"81","author":"CA Linker","year":"1993","unstructured":"Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL (1993). Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen. Blood 81:311.","journal-title":"Blood"},{"key":"10_CR18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V81.2.319.319","volume":"81","author":"NJ Chao","year":"1993","unstructured":"Chao NJ, Stein AS, Long GD, Negrin RS, Amylon MD, Wong RM, Forman SJ, Blume KG (1993). Busulfan\/etoposide\u2014initial experience with a new preparatory regimen for autologous bone marrow transplantation in patients with acute nonlymphoblastic leukemia. Blood 81:319.","journal-title":"Blood"},{"key":"10_CR19","doi-asserted-by":"crossref","first-page":"3810","DOI":"10.1182\/blood.V84.11.3810.bloodjournal84113810","volume":"84","author":"JP Laporte","year":"1994","unstructured":"Laporte JP, Douay L, Lopez M, Labopin M, Jouet JP, Lesage S, Stachowiak J, Fouillard L, Isnard F, Noel-Walter MP, Pene F, Deloux J, Van Den Akker J, Grande M, Bauters F, Najman A, Gorin NC (1994). One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience. Blood 84:3810.","journal-title":"Blood"},{"key":"10_CR20","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1182\/blood.V74.6.1898.1898","volume":"74","author":"M K\u00f6rbling","year":"1989","unstructured":"K\u00f6rbling M, Hunstein W, Fliedner TM, Cayeux S, D\u00f6rken B, Fehrentz D, Haas R, Ho AD, Keilholz U, Knauf W, K\u00f6nig A, Mende U, Pezzutto A, Von Reumont J, Wolf GK, Wannenmacher M, Zum Winkel K, Rother K (1989). Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia. Blood 74: 1898.","journal-title":"Blood"},{"key":"10_CR21","first-page":"709","volume-title":"Bone Marrow Transplantation","author":"AM Yeager","year":"1994","unstructured":"Yeager AM (1994). Autologous bone marrow transplantation of acute myeloid leukemia. In Forman SJ, Blume KG, Thomas ED (eds), Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, p. 709."},{"key":"10_CR22","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJM199410063311402","volume":"331","author":"RJ Mayer","year":"1994","unstructured":"Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, Mclntyre OR, Frei E, for the Cancer and Leukemia Group B (1994). Intensive postremission chemotherapy in adults with acute myeloid leukemia. N Engl J Med 331: 896.","journal-title":"N Engl J Med"},{"key":"10_CR23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1200\/JCO.1990.8.2.287","volume":"8","author":"B L\u00f6wenberg","year":"1990","unstructured":"L\u00f6wenberg B, Verdonck LJ, Dekker AW, Willemze R, Zwaan FE, De Planque M, Abels J, Sonneveld P, Van der Lelie J, Goudsmit R, Van Putten WLJ, Sizoo W, Hagenbeek A, de Gast GC (1990). Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. J Clin Oncol 8:287.","journal-title":"J Clin Oncol"},{"key":"10_CR24","first-page":"303","volume":"7","author":"A Ferrant","year":"1991","unstructured":"Ferrant A, Doyen C, Delannoy A, Cornu G, Martiat P, Latinne D, DeBruyere M, Bosly A, Michaux JL, Sokal G (1991). Allogeneic or autologous bone marrow transplantation for acute nonlymphocytic leukemia in first remission. Bone Marrow Transplant 7:303.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2141.1989.tb07652.x","volume":"72","author":"J Reiffers","year":"1989","unstructured":"Reiffers J, Gaspard MH, Maraninchi D, Michallet M, Marit G, Stoppa AM, Corront B, David B, Gastaut JA, Sotto JJ, Boustet A, Carcassonne Y, Hollard D (1989). Comparison of allogeneic or autologous bone marrow transplantation and chemotherapy in patients with acute myeloid leukaemia in first remission: prospective controlled trial. Br J Haematol 72:57.","journal-title":"Br J Haematol"},{"key":"10_CR26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1200\/JCO.1994.12.6.1169","volume":"12","author":"WS Velasquez","year":"1994","unstructured":"Velasquez WS, McLaughlin P, Tucker S, Hagemeister FB, Swan F, Rodriguez MA, Romaguera J, Rubenstein E, Cabanillas F (1994). ESHAP\u2014an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4 year follow-up study. J Clin Oncol 12:1169.","journal-title":"J Clin Oncol"},{"issue":"Suppl l","key":"10_CR27","first-page":"252a","volume":"84","author":"AK Barnett","year":"1994","unstructured":"Barnett AK, Goldstone AH, Stevens RF, Hann IM, Rees JK, Wheatley K, Gray RG (1994). The role of BMT in addition to intensive chemotherapy in AML in first CR: results of the MRC AML-10 trial. Blood 84 (Suppl l):252a.","journal-title":"Blood"},{"key":"10_CR28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1056\/NEJM199501263320411","volume":"332","author":"B L\u00f6wenberg","year":"1995","unstructured":"L\u00f6wenberg B (1995). Post-remission treatment of acute myelogenous leukemia. N Engl J Med 332:260.","journal-title":"N Engl J Med"},{"issue":"Sl","key":"10_CR29","first-page":"201a","volume":"84","author":"A Keating","year":"1994","unstructured":"Keating A, Rowlings PA, Horowitz MM, Dicke K, Gale RP, Klein JP (1994). Comparison of HLA-identical sibling and autologous bone marrow transplants for acute myelogenous leukemia. Blood 84 Sl:201a.","journal-title":"Blood"},{"key":"10_CR30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood.V74.1.501.501","volume":"74","author":"SD Rowley","year":"1989","unstructured":"Rowley SD, Jones RJ, Piantadosi S, Braine HG, Colvin OM, Davis J, Sarai R, Sharkis S, Wingard J, Yeager AM, Santos GW (1989). Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia. Blood 74:501.","journal-title":"Blood"},{"key":"10_CR31","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1182\/blood.V78.4.1125.1125","volume":"78","author":"CB Miller","year":"1991","unstructured":"Miller CB, Zehnbauer BA, Piantadosi S, Rowley SD, Jones RJ (1991). Correlation of occult clonogeneic leukemia drug sensitivity with relapse after autologous bone marrow transplantation. Blood 78:1125.","journal-title":"Blood"},{"key":"10_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","volume":"341","author":"MK Brenner","year":"1993","unstructured":"Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN (1993). Gene-marking to trace origin or relapse after autologous bone-marrow transplantation. Lancet 341:85.","journal-title":"Lancet"},{"key":"10_CR33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1182\/blood.V67.5.1367.1367","volume":"67","author":"NC Gorin","year":"1986","unstructured":"Gorin NC, Douay L, Laporte JP, et al. (1986). Autologous bone marrow transplantation using marrow incubated with AstaZ7557 in adult acute leukemia. Blood 67:1367.","journal-title":"Blood"},{"key":"10_CR34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1084\/jem.171.2.477","volume":"171","author":"K Miyake","year":"1990","unstructured":"Miyake K, Medina KL, Hayashi S-I, Ono S, Hamaoka T, Kincade PW (1990). Monoclonal antibodies to Pgp-1\/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171:477.","journal-title":"J Exp Med"},{"key":"10_CR35","first-page":"669","volume":"4","author":"P Fabritiis De","year":"1989","unstructured":"De Fabritiis P, Ferrero D, Sandrelli A, Tarella C, Meloni G, Pulsoni A, Pregno P, Badoni R, De Felice L, Gllo E, Amadori S, Mandelli F, Pileri A (1989). Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission. Bone Marrow Transplant 4:669.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR36","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood.V79.9.2229.2229","volume":"79","author":"MJ Robertson","year":"1992","unstructured":"Robertson MJ, Soiffer RJ, Freedman AS, Rabinowe SL, Anderson KC, Ervin TJ, Murray C, Dear K, Griffin JD, Nadler LM, Ritz J (1992). Human bone marrow depletd of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia. Blood 79:2229.","journal-title":"Blood"},{"key":"10_CR37","first-page":"103","volume":"10","author":"BS Charak","year":"1992","unstructured":"Charak BS, Choudhary GD, Tefft M, Mazumder A (1992). Interleukin-2 in bone marrow transplantation: preclinical studies. Bone Marrow Transplant 10:103.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00007890-199307000-00006","volume":"56","author":"BS Charak","year":"1993","unstructured":"Charak BS, Brynes RK, Chogyoji M, Kortes V, Tefft M, Mazumder A (1993). Graft versus leukemia effects after transplantation with interleukin-2-activated bone marrow: correlation with eradication of residual disease. Transplantation 56:31.","journal-title":"Transplantation"},{"key":"10_CR39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.V76.3.480.480","volume":"76","author":"AK McMillan","year":"1990","unstructured":"McMillan AK, Goldstone AH, Linch DC, Gribben JG, Patterson KG, Richards JDM, Franklin I, Boughton BJ, Milligan DW, Leyland M, Hutchison RM, Newland AC (1990). High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemia. Blood 76:480.","journal-title":"Blood"},{"key":"10_CR40","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood.V75.8.1606.1606","volume":"75","author":"NC Gorin","year":"1990","unstructured":"Gorin NC, Aegerter P, Auvert B, Meloni G, Goldstone AH, Burnett A, Carella A, Korbling M, Herve P, Maraninchi D, L\u00f6wenberg R, Verdonck LF, De Planque M, Hermans J, Helbig W, Porcellini A, Rizzoli V, Alesandrino EP, Franklin IM, Reiffers J, Colleselli P, Goldman JM (1990). Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: a European survey of the role of marrow purging. Blood 75:1606.","journal-title":"Blood"},{"key":"10_CR41","first-page":"913","volume-title":"Bone Marrow Transplantation","author":"EJ Shpall","year":"1994","unstructured":"Shpall EJ, Jones RB (1994). Mobilization and collection of peripheral blood progenitor cells for support of high-dose cancer chemotherapy. In Forman SJ, Blume KG, Thomas ED (eds), Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, p. 913."},{"key":"10_CR42","first-page":"343","volume":"7","author":"M \u00f6rbling","year":"1991","unstructured":"K\u00f6rbling M, Fliedner TM, Holle R, Magrin S, Baumann M, Holdermann E, Eberhardt K (1991). Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AML: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease-free survival. Bone Marrow Transplant 7:343.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR43","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1200\/JCO.1993.11.9.1661","volume":"11","author":"MA Sanz","year":"1993","unstructured":"Sanz MA, De la Rubia J, Sanz GF, Mart\u00edn G, Mart\u00ednez J, Jarque I, Sempere A, Gomis F, Senent L, Soler MA, L\u00f3pez F, Arilla MJ, Carpio N, Guinot M, Palau J, Tudela M, Marty ML (1993). Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution. J Clin Oncol 11:1661.","journal-title":"J Clin Oncol"},{"key":"10_CR44","first-page":"731","volume-title":"Bone Marrow Transplantation","author":"J Ritz","year":"1994","unstructured":"Ritz J, Ramsay NK, Kersey JH (1994). Autologous bone marrow transplantation for acute lymphoblastic leukemia. In Forman SJ, Blume KG, Thomas ED (eds), Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, p. 731."},{"key":"10_CR45","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199310283291801","volume":"329","author":"GK Rivera","year":"1993","unstructured":"Rivera GK, Pinkel D, Simone JV, Hancock ML, Crist WM (1993). Treatment of acute lymphoblastic leukemia\u201430 years\u2019 experience at St. Jude Children\u2019s Research Hospital. N Engl J Med 329:1289.","journal-title":"N Engl J Med"},{"key":"10_CR46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0889-8588(18)30261-2","volume":"7","author":"DF Hoelzer","year":"1993","unstructured":"Hoelzer DF (1993). Therapy of the newly diagnosed adult with acute lymphoblastic leukemia. Hematol\/Oncol Clin North Am 7:139.","journal-title":"Hematol\/Oncol Clin North Am"},{"key":"10_CR47","first-page":"11","volume":"7","author":"H Schroeder","year":"1991","unstructured":"Schroeder H, Pinkerton CR, Powles RL, Meller ST, Tait D, Milan S, McElwain TJ (1991). High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse. Bone Marrow Transplant 7:11.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR48","first-page":"349","volume":"3","author":"HP Davis","year":"1988","unstructured":"Davis HP, Revell P, Giangrande P, Flanagan P, Poynton CH, Bampton S, Phillips R, Barrett AJ (1988). Safe application of a 13-Gy split dose total body irradiation schedule prior to bone marrow transplantation. Bone Marrow Transplant 3:349.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR49","first-page":"19","volume":"8","author":"MJML Gilmore","year":"1991","unstructured":"Gilmore MJML, Hamon MD, Prentice HG, Katz F, Slaper-Cortenbach ICM, Hunter AE, Gandhi L, Brenner MK, Hoffbrand AV, Mehta AB, Seeker-Walker LM, Skeggs D, Collis CH (1991). Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission. Bone Marrow Transplant 8:19.","journal-title":"Bone Marrow Transplant"},{"issue":"Sl","key":"10_CR50","first-page":"202a","volume":"84","author":"D Fi\u00e8re","year":"1994","unstructured":"Fi\u00e8re D, Sebban C, Vernant JP, Witz F, Rigal-Huguet F, Boucheix C, Racadot E, Pignon B, Delannoy A, Reiffers J, Sutton L, Archimbaud E, Lepage E (1994). Long term results of chemotherapy, allogeneic or autologous bone marrow transplantation (BMT) as post remission therapy in adult acute lymphoblastic leukemia (ALL) for patients included in a prospective multicentric trail (LALA 87). Blood 84 (Suppl l):251a.","journal-title":"Blood"},{"issue":"Supp11","key":"10_CR51","first-page":"251a","volume":"84","author":"M Attal","year":"1994","unstructured":"Attal M, Blaise D, Marrit G, Michalet M, Vernant JP, Sauvage C, Troussard X, Nedellec G, Pico J, Huguet F, Stoppa AM, Sotto JJ, Reiffers J, Maraninchi D, Paven C, Pris J (1994). Consolidation treatment of adult acute lymphoblastic leukemia (ALL): a prospective study comparing allo-BMT versus auto-BMT and testing the impact of IL2 after auto-BMT. Blood 84 (Suppl l):251a.","journal-title":"Blood"},{"key":"10_CR52","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1182\/blood.V79.11.3067.3067","volume":"79","author":"AJ Barrett","year":"1992","unstructured":"Barrett AJ, Horowitz MM, Ash RC, Atkinson K, Gale RP, Goldman JM, Henslee-Downey PJ, Herzig RH, Speck B, Zwaan FE, Bortin MM (1992). Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 79:3067.","journal-title":"Blood"},{"key":"10_CR53","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood.V78.8.1923.1923","volume":"78","author":"NJ Chao","year":"1991","unstructured":"Chao NJ, Forman SJ, Schmidt GM, Snyder DS, Amylon MD, Konrad PN, Nademanee AP, O\u2019Donnell MR, Parker PM, Stein AS, Smith E, Wong RM, Hoppe RT, Blume KG (1991). Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia during first complete remission. Blood 78:1923.","journal-title":"Blood"},{"key":"10_CR54","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1200\/JCO.1989.7.11.1594","volume":"7","author":"SE Sallan","year":"1989","unstructured":"Sallan SE, Niemeyer CM, Billett AL, Lipton JM, Tarbeil NJ, Gelber RD, Murray C, Pittinger TP, Wolfe LC, Bast RC Jr, Ritz J (1989). Autologous bone marrow transplantation for acute lymphoblastic leukemia. J Clin Oncol 7:1594.","journal-title":"J Clin Oncol"},{"key":"10_CR55","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198708203170801","volume":"317","author":"JH Kersey","year":"1987","unstructured":"Kersey JH, Weisdorf D, Nesbit ME, LeBien TW, Woods WG, McGlave PB, Kim T, Vallera DA, Goldman AI, Bostrom B, Hurd D, Ramsay NKC (1987). Comparison of autologous and allogeneic bone marrow transplantation for treatment of high risk refractory acute lymphoblastic leukemia in second remission. N Engl J Med 317:461.","journal-title":"N Engl J Med"},{"key":"10_CR56","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood.V74.3.1152.1152","volume":"74","author":"FWMB Preijers","year":"1989","unstructured":"Preijers FWMB, de Witte T, Wessels JMC, de Gast GC, Van Leeuwen E, Capel PJA, Haanen C (1989). Autologous transplantation of bone marrow purged in vitro with anti-CD7-(WT1-) ricin A immunotoxin in T-cell lymphoblastic leukemia and lymphoma. Blood 74:1152.","journal-title":"Blood"},{"key":"10_CR57","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V76.9.1723.1723","volume":"76","author":"FM Uckun","year":"1990","unstructured":"Uckun FM, Kersey JH, Vallera DA, Ledbetter JA, Weisdorf D, Myers DE, Haake R, Ramsay NKC (1990). Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukermia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging. Blood 76:1723.","journal-title":"Blood"},{"key":"10_CR58","first-page":"301","volume":"6","author":"AM Stoppa","year":"1990","unstructured":"Stoppa AM, Hirn J, Blaise D, Delaage M, Novakovitch G, Viens P, Capiello MA, Mannoni P, Mawas C, Maraninchi D (1990). Autologous bone marrow transplantation for B cell malignancies after in vitro purging with floating immunobeads. Bone Marrow Transplant 6:301.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR59","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/mpo.2950190303","volume":"19","author":"R Gonzalez-Chambers","year":"1991","unstructured":"Gonzalez-Chambers R, Przepiorka D, Shadduck RK, Borochovitz D, Bloom E, Colvin OM, Mangan KF, Rosenfeld CS (1991). Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow for acute lymphoblastic leukemia. Med Pediat Oncol 19:160.","journal-title":"Med Pediat Oncol"},{"key":"10_CR60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev.me.40.020189.000531","volume":"40","author":"GW Santos","year":"1989","unstructured":"Santos GW, Yeager AM, Jones RJ (1989). Autologous bone marrow transplantation. Annu Rev Med 40:99.","journal-title":"Annu Rev Med"},{"key":"10_CR61","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood.V65.2.289.289","volume":"65","author":"P Casellas","year":"1985","unstructured":"Casellas P, Canat X, Fausere A, et al. (1985). Optimal elimination of leukemic T-cells from human bone marrow with T101 ricin A-chain immunotoxin. Blood 65:289.","journal-title":"Blood"},{"key":"10_CR62","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJM199310283291802","volume":"329","author":"FM Uckun","year":"1993","unstructured":"Uckun FM, Kersey JH, Haake R, Weisdorf D, Nesbit ME, Ramsay NKC (1993). Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N Engl J Med 329:1296.","journal-title":"N Engl J Med"},{"key":"10_CR63","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1182\/blood.V82.3.691.691","volume":"82","author":"HM Kantarjian","year":"1993","unstructured":"Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M (1993). Chronic myelogenous leukemia: a concise update. Blood 82:691.","journal-title":"Blood"},{"key":"10_CR64","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.V82.7.1954.1954","volume":"82","author":"RA Clift","year":"1993","unstructured":"Clift RA, Appelbaum FR, Thomas ED (1993). Treatment of chronic myeloid leukemia by marrow transplantation. Blood 82:1954.","journal-title":"Blood"},{"key":"10_CR65","first-page":"143","volume-title":"Important Advances in Oncology","author":"A Fefer","year":"1990","unstructured":"Fefer A, Thomas ED (1990). Bone marrow transplantation for chronic myelogenous leukemia. In De Vita VTJ, Hellman S, Rosenberg SA (eds), Important Advances in Oncology 1990. J.B. Lippincott: Philadelphia, p. 143."},{"issue":"Suppl l","key":"10_CR66","first-page":"252a","volume":"84","author":"A Fefer","year":"1994","unstructured":"Fefer A, Radich J, Pavletic Z, Cheever MA, Greenberg PD, Appelbaum FR, Clift RA, Storb R, Sanders J, Sullivan K, Buckner CD, Thomas ED (1994). Syngeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: update of the original 14 Seattle patients. Blood 84 (Suppl l):252a.","journal-title":"Blood"},{"key":"10_CR67","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V84.3.724.724","volume":"84","author":"MJ Barnett","year":"1994","unstructured":"Barnett MJ, Eaves CJ, Phillips GL, Gascoyne RD, Hogge DE, Horsman DE, Humphries RK, Klingemann H, Lansdorp PM, Nantel SH, Reece DE, Shepherd JD, Spinelli JJ, Sutherland HJ, Eaves AC (1994). Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood 84:724.","journal-title":"Blood"},{"key":"10_CR68","first-page":"517","volume":"5","author":"AM Carella","year":"1991","unstructured":"Carella AM, Gaozza E, Raffo MR, Carlier P, Frassoni F, Valbonesi M, Lercari G, Sessarego M, Defferrari R, Guerrasio A, Saglio G, Canepa L, Gaetani GF, Occhini D (1991). Therapy of acute phase chronic myelogenous leukemia with intensive chemotherapy, blood cell autotransplant and cyclosporine A. Leukemia 5:517.","journal-title":"Leukemia"},{"key":"10_CR69","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1200\/JCO.1986.4.6.906","volume":"4","author":"L Vellekoop","year":"1986","unstructured":"Vellekoop L, Zander AR, Kantarjian HM, Jagannath S, Hester JP, Trujillo J, McCredie KB, Zagars G, Spitzer G, Dicke KA (1986). Piperazinedione, total body irradiation and autologous bone marrow transplantation in chronic myelogenous leukemia. J Clin Oncol 4:906.","journal-title":"J Clin Oncol"},{"key":"10_CR70","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1994.12.12.2527","volume":"12","author":"DL Darrington","year":"1994","unstructured":"Darrington DL, Vose JM, Anderson JR, Bierman PJ, Bishop MR, Chan WC, Morris ME, Reed EC, Sanger WG, Tarantolo SR, Weisenburger DD, Kessinger A, Armitage JO (1994). Incidence and characterization of secondary myelodysplastic syndromes and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stem cell transplantation for lymphoid malignancies. J Clin Oncol 12:2527.","journal-title":"J Clin Oncol"},{"key":"10_CR71","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1182\/blood.V79.4.1003.bloodjournal7941003","volume":"79","author":"CM Verfaillie","year":"1992","unstructured":"Verfaillie CM, Miller WJ, Boylan K, McGlave PB (1992). Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood 79:1003.","journal-title":"Blood"},{"issue":"Supp11","key":"10_CR72","first-page":"537a","volume":"84","author":"M Talpaz","year":"1994","unstructured":"Talpaz M, Kantarjian H, Khouri I, Gajewski J, Przepiorka D, Giralt S, Mehra R, van Besien K, Claxton D, Andersson B, Hester J, Korbling M, Berenson R, Heimfeld S, Calvert L, Hamer J, Tibbits P, Liang J, Champlin R, Deisseroth AB (1994). Diploid cells collected from chronic myelogenous leukemia patients during recovery from conventional dose-induced myelosuppression generate complete cytogenetic remissions after autologous transplantation. Blood 84 (Suppl l):537a.","journal-title":"Blood"},{"key":"10_CR73","first-page":"S3:S45","volume":"14","author":"C Carlo-Stella","year":"1994","unstructured":"Carlo-Stella C, Mangoni L, Piovani C, Garau D, Dotti GP, Almici C, Rizzoli V (1994). Selection of Philadelphia-negative progenitors from chronic myelogenous leukemia. Bone Marrow Transplant 14 S3:S45 (abstract).","journal-title":"Bone Marrow Transplant"},{"key":"10_CR74","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1200\/JCO.1994.12.12.2543","volume":"12","author":"C Haioun","year":"1994","unstructured":"Haioun C, Lepage E, Gisselbrecht C, Coiffier B, Bosly A, Tilly H, Morel P, Nouvel C, Herbrecht R, D\u2019Agay MF, Gaulard P, Reyes F, for the Groups d\u2019Etudes des Lymphomes de l\u2019Adulte (1994). Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin\u2019s lymphoma in first complete remission: a study of 464 patients. J Clin Oncol 12:2543.","journal-title":"J Clin Oncol"},{"key":"10_CR75","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1200\/JCO.1994.12.12.2552","volume":"12","author":"S Horning","year":"1994","unstructured":"Horning S, Negrin RS, Chao NJ, Long GD, Hoppe RT, Blume KG (1994). Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma. J Clin Oncol 12:2552.","journal-title":"J Clin Oncol"},{"key":"10_CR76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.1994.tb03255.x","volume":"86","author":"C Hoyle","year":"1994","unstructured":"Hoyle C, Gray R, Goldman J (1994). Autografting for patients with CML in chronic phase: an update. Br J Haematol 86:76.","journal-title":"Br J Haematol"},{"key":"10_CR77","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/S0140-6736(94)92589-5","volume":"343","author":"P McGlave","year":"1994","unstructured":"McGlave P, De Fabritiis P, Deisseroth AB, Goldman J, Barnett M, Reiffers J, Simonsson B, Carella A, Aeppli D (1994). Autologous transplants for chronic myelogenous leukemia: results form eight transplant groups. Lancet 343:1486.","journal-title":"Lancet"},{"issue":"Suppl l","key":"10_CR78","first-page":"537a","volume":"84","author":"HM Kantarjian","year":"1994","unstructured":"Khouri IF, Kantarjian HM, Talpaz M, Rios MB, Giralt S, Hester JP, Champlin RE, Deisseroth AB (1994). High-dose chemotherapy and unpurged autologous stem cell transplantation for chronic myelogenous leukemia: the M.D. Anderson experience. Blood 84 (Suppl l):537a.","journal-title":"Blood"},{"key":"10_CR79","unstructured":"Talpaz M, Kantarjian H, Liang J, Calvert L, Hamer J, Tibbits P, Durett A, Claxton D, Giralt S, Khouri I, Przepiorka D, van Besien K, Andersson B, Mehra R, Gajewski J, Seong D, Hester J, Estey E, Korbling M, Pollicardo N, Berenson R, Heimfeld S, Champlin R, Deisseroth AB (in press). Percent of Ph-negative and Ph-positive cells found after autologous transplantation for chronic myelogenous leukemia (CML) depends on percent of diploid cells induced by conventional dose chemotherapy before collection of autologous cells. Blood."},{"key":"10_CR80","first-page":"S3:S34","volume":"14","author":"AM Carella","year":"1994","unstructured":"Carella AM, Frassoni F, Pollicardo N, Pungolino E, Podest\u00e0 M, Giordano D, Ferrero R, Soracco M, Benvenuto F, Figari O (1994). Ph-negative blood progenitor cells (BPCs) can be recruited after chemotherapy and G-CSF during early hemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea. Bone Marrow Transplant 14 S3:S34 (abstract).","journal-title":"Bone Marrow Transplant"},{"key":"10_CR81","first-page":"S3:S55","volume":"14","author":"B Simonsson","year":"1994","unstructured":"Simonsson B, \u00d6berg G, Killander A, Bj\u00f6rkholm M, Gahrton G, Stenke L, Turesson I, Ud\u00e9n A, Claes M, Vil\u00e9n L, Wahlin A, L\u00f6fvenberg E, Carneskog J, Westin J (1994). Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenous leukemia (CML). Bone Marrow Transplant 14 S3:S55 (abstract).","journal-title":"Bone Marrow Transplant"},{"key":"10_CR82","first-page":"96","volume":"6","author":"CD Buckner","year":"1978","unstructured":"Buckner CD, Stewart P, Clift RA, Fefer A, Neiman PE, Singer J, Storb R, Thomas ED (1978). Treatment of blastic transformation of chronic granulocytic leukemia by chemotherapy, total body irradiation and infusion of cryopreserved autologous marrow. Exp Hematol 6:96.","journal-title":"Exp Hematol"},{"key":"10_CR83","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2141.1991.tb08581.x","volume":"77","author":"J Reiffers","year":"1991","unstructured":"Reiffers J, Trouette R, Marit G, Montastruc M, Fab\u00e8res C, Cony-Makhoul P, David B, Bourdeau MJ, Bilhou-Nabera C, Lacombe F, Feuillatre-Fabre F, Vezon G, Bernard P, Broustet A (1991). Autologous blood stem cell transplantation for chronic granulocytic leukaemia in transformation: a report of 47 cases. Br J Haematol 77:339.","journal-title":"Br J Haematol"},{"key":"10_CR84","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","volume":"316","author":"T Philip","year":"1987","unstructured":"Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn JY, Colombat P, Goldstone A, Gorin NC, Flesh M, Laporte JP, Maraninchi D, Pico J, Bosly A, Anderson C, Schots R, Biron P, Cabanillas F, Dicke K (1987). High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high-grade-non-Hodgkin\u2019s lymphoma. N Engl J Med 316:1493.","journal-title":"N Engl J Med"},{"key":"10_CR85","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM198706113162402","volume":"316","author":"T Takvorian","year":"1987","unstructured":"Takvorian T, Canellos CP, Ritz J, Freedman AS, Anderson KC, Mauch P, Tarbell N, Coral F, Daley H, Yeap B, Schlossman SF, Nadler LM (1987). Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin\u2019s lymphoma with a poor prognosis. N Engl J Med 316:1499.","journal-title":"N Engl J Med"},{"key":"10_CR86","first-page":"135","volume":"8","author":"DJ Weisdorf","year":"1991","unstructured":"Weisdorf DJ, Haake R, Miller WJ, McGlave PB, LeBien TW, Vallera DA, Lasky LC, Kim TH, Peterson BA, Ramsay NKC, Kersey JH, Hurd DD (1991). Autologous bone marrow transplantation for progressive non-Hodgkin\u2019s lymphoma: clinical impact of immunophenotype and in vitro purging. Bone Marrow Transplant 8:135.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR87","first-page":"483","volume":"4","author":"FB Petersen","year":"1989","unstructured":"Petersen FB, Appelbaum FR, Bigelow CL, Buckner CD, Clift RA, Sanders JE, Storb R, Sullivan KM, Weiden PL, Fefer A, Thomas ED (1989). High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma. Bone Marrow Transplant 4:483.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR88","first-page":"1","volume":"3","author":"FR Appelbaum","year":"1993","unstructured":"Appelbaum FR (1993). Treatment of aggressive non-Hodgkin\u2019s lymphoma with marrow transplantation. Marrow Transplant Rev 3:1.","journal-title":"Marrow Transplant Rev"},{"key":"10_CR89","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1200\/JCO.1990.8.4.638","volume":"8","author":"FB Petersen","year":"1990","unstructured":"Petersen FB, Appelbaum FR, Hill R, Fisher LD, Bigelow CL, Sanders JE, Sullivan KM, Bensinger WI, Witherspoon RP, Storb R, Clift RA, Fefer A, Press OW, Weiden PL, Singer J, Thomas ED, Buckner CD (1990). Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle. J Clin Oncol 8:638.","journal-title":"J Clin Oncol"},{"key":"10_CR90","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1200\/JCO.1993.11.10.1846","volume":"11","author":"JM Vose","year":"1993","unstructured":"Vose JM, Anderson JR, Kessinger A, Bierman PJ, Coccia P, Reed EC, Gordon B, Armitage JO (1993). High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for agressive non-Hodgkin\u2019s lymphoma. J Clin Oncol 11:1846.","journal-title":"J Clin Oncol"},{"key":"10_CR91","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1200\/JCO.1990.8.4.630","volume":"8","author":"P Colombat","year":"1990","unstructured":"Colombat P, Gorin N-C, Lemonnier M-P, Binet C, Laporte J-P, Douay L, Desbois I, Lopez M, Lamagnere J-P, Najman A (1990). The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin\u2019s lymphomas. J Clin Oncol 8:630.","journal-title":"J Clin Oncol"},{"key":"10_CR92","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1200\/JCO.1993.11.12.2351","volume":"11","author":"AP Rapoport","year":"1993","unstructured":"Rapoport AP, Rowe JM, Kouides PA, Duerst RA, Abboud CN, Liesveld JL, Packman CH, Eberly S, Sherman M, Tanner MA, Constine LS; DiPersio JF (1993). One hundred autotransplants for relapsed or refractory Hodgkin\u2019s disease and lymphoma: value of pretransplant disease status for predicting outcome. J Clin Oncol 11:2351.","journal-title":"J Clin Oncol"},{"key":"10_CR93","unstructured":"Van Besien KW, Tabocoff J, Rodriguez MA, Andersson B, Mehra R, Przepiorka D, Dimopoulos M, Giralt SA, Suki S, Khouri I, Hughes P, Spitzer G, Jagannath S, Dicke K, LeMaistre CF, Deisseroth AB, Cabanillas F, Champlin R (in press). Intensive chemotherapy with the BEAC regimen and autologous bone marrow transplantation in patients with refractory or recurrent intermediate grade and immunoblastic lymphoma; toxicity, long-term follow-up and identification of prognostic factors. Bone Marrow Transplant."},{"key":"10_CR94","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1200\/JCO.1993.11.6.1085","volume":"11","author":"C Wheeler","year":"1993","unstructured":"Wheeler C, Strawderman M, Ayash L, Hallowell Churchill W, Bierer BE, Elias A, Gilliland DG, Antman K, Guinan EC, Eder JP, Weinstein H, Schwartz G, Ferrara J, Mazanet R, Rimm IJ, Tepler I, McCarthy P, Mauch P, Ault K, Gaynes L, McCauley M, Schnipper LE, Antin J (1993). Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin\u2019s lymphoma with cyclophosphamide, carmustine, and etoposide. J Clin Oncol 11:1085.","journal-title":"J Clin Oncol"},{"key":"10_CR95","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1200\/JCO.1994.12.12.2559","volume":"12","author":"CH Weaver","year":"1994","unstructured":"Weaver CH, Petersen FB, Appelbaum FR, Bensinger WI, Press O, Martin P, Sandmaier B, Deeg HJ, Hansen JA, Brunvand M, Rowley S, Benyunes K, Chauncy T, Fefer A, Hackman R, Gooley T, Schiffman K, Storb R, Sullivan KM, Weiden P, Witherspoon R, Buckner CD (1994). High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma. J Clin Oncol 12:2559.","journal-title":"J Clin Oncol"},{"key":"10_CR96","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1182\/blood.V75.4.831.831","volume":"75","author":"GL Phillips","year":"1990","unstructured":"Phillips GL, Fay JW, Herzig RH, Lazarus HM, Wolff SN, Lin H, Shina DC, Glasgow GP, Griffith RC, Lamb CW, Herzig GP (1990). The treatment of progressive non-Hodgkin\u2019s lymphoma with intensive chemoradiotherapy and autologous marrow transplantation. Blood 75:831.","journal-title":"Blood"},{"key":"10_CR97","first-page":"871","volume":"70","author":"JO Armitage","year":"1986","unstructured":"Armitage JO, Gingrich RD, Klassen LW, Bierman PJ, Kumar PP, Weisenburger DD, Smith DM (1986). Trial of high-dose cytarabine, cyclophosphamide, total-body irradiation and autologous marrow transplantation for refractory lymphoma. Cancer Treat Rep 70:871 (abstract).","journal-title":"Cancer Treat Rep"},{"key":"10_CR98","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1200\/JCO.1992.10.12.1949","volume":"10","author":"LF Verdonck","year":"1992","unstructured":"Verdonck LF, Dekker AW, de Gast GC, Van Kempen ML, Lokhorst HM, Nieuwenhuis HK (1992). Salvage therapy with ProMACE-MOPP followed by intensive chemoradiotherapy and autologous bone marrow transplantation for patients with non-Hodgkin\u2019s lymphoma who failed to respond to first-line CHOP. J Clin Oncol 10:1949.","journal-title":"J Clin Oncol"},{"key":"10_CR99","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1200\/JCO.1990.8.5.784","volume":"8","author":"AS Freedman","year":"1990","unstructured":"Freedman AS, Takvorian T, Anderson KC, Mauch P, Rabinowe SN, Blake K, Yeap B, Soiffer R, Coral F, Heflin L, Ritz J, Nadler LM (1990). Autologous bone marrow transplantation in B-cell non-Hodgkin\u2019s lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 8:784.","journal-title":"J Clin Oncol"},{"key":"10_CR100","first-page":"41","volume":"8","author":"R Ghalie","year":"1991","unstructured":"Ghalie R, Richman CM, Adler SS, Korenblit AD, Kramer TS, Manson S, Dolce A, Kaizer H (1991). Involved field radiation, fractionated total body irradiation, high dose cyclophosphamide, and autologous bone marrow transplantation in the treatment of malignant lymphomas. Bone Marrow Transplant 8:41.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR101","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1182\/blood.V65.4.984.984","volume":"65","author":"LF Verdonck","year":"1985","unstructured":"Verdonck LF, Dekker AW, Van Kempen ML, Punt K, Van Unnik JAM, van Peperzeel HA, de Gast GC (1985). Intensive cytotoxic therapy followed by autologous bone marrow transplantation for non-Hodgkin\u2019s lymphoma of high grade malignancy. Blood 65:984.","journal-title":"Blood"},{"key":"10_CR102","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1200\/JCO.1992.10.6.936","volume":"10","author":"S Gulati","year":"1992","unstructured":"Gulati S, Yahalom J, Acaba L, Reich L, Motzer R, Crown J, Toia M, Igarashi T, Lemoli R, Hanninen E, Doherty M (1992). Treatment of patients with relapsed and resistant non-Hodgkin\u2019s lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation. J Clin Oncol 10:936.","journal-title":"J Clin Oncol"},{"key":"10_CR103","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/0277-5379(86)90165-3","volume":"22","author":"G Spitzer","year":"1986","unstructured":"Spitzer G, Japannath S, Dicke KA, Armitage J, Zander AR, Vellekoop L, Horwitz L, Cabanillas F, Zagars GK, Velasquez WS (1986). High dose melphalan and total body irradiation with bone marrow transplantation for refractory malignancies. Eur J Cancer Clin Oncol 22:677.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10_CR104","first-page":"341","volume":"5","author":"ER Broun","year":"1990","unstructured":"Broun ER, Tricot G, Akard L, Nichols C, Cheerva A, Jansen J (1990). Treatment of refractory lymphoma with high dose cytarabine, cyclophosphamide and either TBI or VP-16 followed by autologous bone marrow transplantation. Bone Marrow Transplant 5:341.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR105","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1200\/JCO.1987.5.9.1340","volume":"5","author":"KM Sullivan","year":"1987","unstructured":"Appelbaum FR, Sullivan KM, Buckner CD, Clift RA, Deeg J, Fefer A, Hill R, Mortimer J, Neiman PE, Sanders JE, Singer J, Stewart P, Storb R, Thomas ED (1987). Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation and marrow transplantation. J Clin Oncol 5:1340.","journal-title":"J Clin Oncol"},{"key":"10_CR106","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1182\/blood.V77.7.1587.1587","volume":"77","author":"T Philip","year":"1991","unstructured":"Philip T, Chauvin F, Armitage J, Bron D, Hagenbeek A, Biron P, Spitzer G, Velasquez W, Weisenburger DD, Fernandez-Ranada J, Somers R, Rizzoli V, Harousseau JL, Sotto JJ, Cahn JY, Guilhot F, Biggs J, Sonneveld P, Misset JL, Manna A, Jagannath S, Guglielmi C, Chevreau C, Delmer A (1991). Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation. Blood 77:1587.","journal-title":"Blood"},{"key":"10_CR107","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archinte.1981.00340060066015","volume":"141","author":"JS Gottdiener","year":"1981","unstructured":"Gottdiener JS, Appelbaum FR, Ferrans VJ, Deisseroth AB, Ziegler J (1981). Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 141:758.","journal-title":"Arch Intern Med"},{"key":"10_CR108","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H","volume":"57","author":"B Cazin","year":"1986","unstructured":"Cazin B, Gorin NC, Laporte JP, Gallet B, Douay L, Lopez M, Najman A, Duhamel G (1986). Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer 57:2061.","journal-title":"Cancer"},{"key":"10_CR109","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0140-6736(76)90151-3","volume":"i","author":"FR Appelbaum","year":"1976","unstructured":"Appelbaum FR, Strauchen JA, Graw RG, Savage DD, Kent KM, Ferrans VJ, Herzig GP (1976). Acute lethal carditis caused by high-dose combination chemotherapy. Lancet i:58.","journal-title":"Lancet"},{"key":"10_CR110","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood.V75.12.2276.2276","volume":"75","author":"RD Gingrich","year":"1990","unstructured":"Gingrich RD, Ginder GD, Burns LJ, Wen B-C, Fyfe MA (1990). BVAC ablative chemotherapy followed by autologous bone marrow transplantation for patients with advanced lymphoma. Blood 75:2276.","journal-title":"Blood"},{"key":"10_CR111","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1200\/JCO.1989.7.11.1621","volume":"7","author":"JG Gribben","year":"1989","unstructured":"Gribben JG, Goldstone AH, Linch DC, Taghipour G, McMillan AK, Souhami RL, Earl H, Richards JDM (1989). Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin\u2019s lymphomas who are still responsive to conventional-dose therapy. J Clin Oncol 7:1621.","journal-title":"J Clin Oncol"},{"key":"10_CR112","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1200\/JCO.1990.8.10.1728","volume":"8","author":"JA Neidhart","year":"1990","unstructured":"Neidhart JA, Kohler W, Stidley C, Mangalik A, Plauche A, Anderson T, Quenzer RW, Rinehart JJ (1990). Phase I study of repeated cycles of high-dose cyclophosphamide, etoposide, and cisplatin administered without bone marrow transplantation. J Clin Oncol 8:1728.","journal-title":"J Clin Oncol"},{"key":"10_CR113","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1200\/JCO.1992.10.11.1682","volume":"10","author":"HM Lazarus","year":"1992","unstructured":"Lazarus HM, Crilley P, Ciobanu N, Creger RJ, Fox RM, Shina DC, Bulova SI, Gucalp R, Cooper BW, Topolsky D, Soegiarso W, Brodsky I (1992). High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma. J Clin Oncol 10:1682.","journal-title":"J Clin Oncol"},{"issue":"Suppl l","key":"10_CR114","first-page":"146a","volume":"82","author":"KW Besien Van","year":"1993","unstructured":"Van Besien KW, Mehra R, Khouri I, Giralt SA, Andersson B, Dimopoulos M, Przepiorka D, Gajewski J, Rodriguez A, Besa P, Deisseroth AB, Champlin R (1993). Double intensification and allogeneic or autologous bone marrow transplantation for poor prognosis lymphoma. Blood 82 (Suppl l):146a (abstract).","journal-title":"Blood"},{"key":"10_CR115","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1200\/JCO.1992.10.11.1712","volume":"10","author":"WH Wilson","year":"1992","unstructured":"Wilson WH, Jain V, Bryant G, Cowan KH, Carter C, Cottier-Fox M, Goldspiel B, Steinberg SM, Longo DL, Wittes RE (1992). Phase I and II study of high-dose ifosfamide, carboplatin, and etoposide with autologous bone marrow rescue in lymphomas and solid tumors. J Clin Oncol 10:1712.","journal-title":"J Clin Oncol"},{"key":"10_CR116","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1200\/JCO.1994.12.11.2423","volume":"12","author":"DP Schenkein","year":"1994","unstructured":"Schenkein DP, Dixon P, Desforges JF, Berkman E, Erban JK, Ascensao JL, Miller KB (1994). Phase I\/II study of cyclophosphamide, carboplatin and etoposide and autologous hematopoietic stem cell transplantation with posttransplant interferon alfa-2b for patients with lymphoma and Hodgkin\u2019s disease. J Clin Oncol 12:2423.","journal-title":"J Clin Oncol"},{"key":"10_CR117","first-page":"211","volume":"8","author":"RHC Jagt Van der","year":"1991","unstructured":"Van der Jagt RHC, Appelbaum FR, Petersen FB, Bigelow CL, Fisher LD, Schoch GH, Buckner CD, Sanders JE, Storb R, Sullivan KM, Thomas ED (1991). Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy. Bone Marrow Transplant 8:211.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR118","unstructured":"Przepiorka D, Nath R, Ippoliti C, Mehra R, Hagemeister F, Diener K, Dimopoulos M, Giralt S, Khouri I, Samuels B, van Besien K, Andersson B, Deisseroth AB, Luna M, Cabanillas F, Champlin R (in press). A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for autologous transplantation for malignant lymphoma. Leuk Lymphoma."},{"key":"10_CR119","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0272-6386(12)80079-5","volume":"15","author":"HT Robertson","year":"1990","unstructured":"Robertson HT, Haley NR, Guthrie M, Cardenas D, Eschbach JW, Adamson JW (1990). Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients. Am J Kidney Dis 15:325.","journal-title":"Am J Kidney Dis"},{"key":"10_CR120","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn J-Y, Harousseau J-L, Coiffier B, Biron P, Mandelli F, Chauvin F (1995). Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma. N Engl J Med 333: 1540.","journal-title":"N Engl J Med"},{"key":"10_CR121","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1200\/JCO.1992.10.10.1615","volume":"10","author":"A Bosly","year":"1992","unstructured":"Bosly A, Coiffier B, Gisselbrecht C, Tilly H, Auzanneau G, Andrien F, Herbrecht R, Legros M, Devaux Y, Jaubert J, Pignon B, Michaux J-L, Humblet Y, Dupriez B, Thyss A, Lederlin P (1992). Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. J Clin Oncol 10:1615.","journal-title":"J Clin Oncol"},{"key":"10_CR122","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.1993.11.5.931","volume":"11","author":"AS Freedman","year":"1993","unstructured":"Freedman AS, Takvorian T, Neuberg D, Mauch P, Rabinowe SN, Anderson KC, Soiffer RJ, Spector N, Grossbard M, Robertson MJ, Blake K, Coral F, Canellos GP, Ritz J, Nadler LM (1993). Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin\u2019s lymphoma in first remission: a pilot study. J Clin Oncol 11:931.","journal-title":"J Clin Oncol"},{"key":"10_CR123","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V80.5.1130.1130","volume":"80","author":"A Nademanee","year":"1992","unstructured":"Nademanee A, Schmidt GM, O\u2019Donnell MR, Snyder DS, Parker PA, Stein A, Smith E, Lipsett JA, Sniecinski I, Margolin K, Somlo G, Niland JC, Blume KG, Forman SJ (1992). High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot study. Blood 80:1130.","journal-title":"Blood"},{"key":"10_CR124","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1200\/JCO.1988.6.8.1303","volume":"6","author":"SC Gulati","year":"1988","unstructured":"Gulati SC, Shank B, Black P, Yopp J, Koziner B, Straus D, Filippa D, Kempin S, Castro-Malaspina H, Cunningham I, Berman E, Coleman M, Langleben A, Colvin OM, Fuks Z, O\u2019Reilly R, Clarkson B (1988). Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 6:1303.","journal-title":"J Clin Oncol"},{"key":"10_CR125","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project (1993). A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329:987.","journal-title":"N Engl J Med"},{"key":"10_CR126","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199504203321601","volume":"332","author":"LF Verdonck","year":"1995","unstructured":"Verdonck LF, Van Putten WLJ, Hagenbeek A, Schouten HC, Sonneveld P, Van Imhoff GW, Kluin-Nelemans HC, Raemaekers JMM, Van Oers RHJ, Haak HL, Schots R, Dekker AW, De Gast GC, Lowenberg B (1995). Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkins\u2019 lymphoma. N Engl J Med 332: 1045.","journal-title":"N Engl J Med"},{"key":"10_CR127","first-page":"373","volume":"13","author":"M Bregni","year":"1994","unstructured":"Gianni AM, Bregni M, Siena S, Brambilla C, Di Nicola M, Lombardi F, Gandola L, Tarella C, Pileri A, Stern A, Valagussa P, Bonadonna G (1994). 5-Year update of the Milan Cancer Institute randomized trial of high-dose sequential vs MACOP-B therapy for diffuse large cell lymphoma. ASCO Proc 13:373.","journal-title":"ASCO Proc"},{"key":"10_CR128","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.1994.12.12.2524","volume":"12","author":"BA Peterson","year":"1994","unstructured":"Peterson BA (1994). The role of transplantation in non-Hodgkin\u2019s lymphoma. J Clin Oncol 12:2524.","journal-title":"J Clin Oncol"},{"key":"10_CR129","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0277-5379(86)90070-2","volume":"22","author":"T Philip","year":"1986","unstructured":"Philip T, Biron P, Philip I, Favrot M, Souillet G, Frappaz D, Jaubert J, Bordigoni P, Bernard JL, Laporte JP, Lemevel A, Plouvier E, Marguerite G, Pinkerton R, Brizard CP, Freycon F, Forster HK, Philippe N, Brunat-Mentigny M (1986). Massive therapies and autologous bone marrow transplantation in pediatric and young adults with Burkitt\u2019s lymphoma (30 courses on 28 patients: a 5 year experience). Eur J Cancer Clin Oncol 22:1015.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10_CR130","first-page":"784","volume":"8","author":"T Philip","year":"1988","unstructured":"Philip T, Hartman O, Brian P, et al. (1988). High dose therapy and autologous bone marrow transplantation in partial remission after first line induction therapy for diffuse non-Hodgkins lymphoma. J Clin Oncol 8:784.","journal-title":"J Clin Oncol"},{"key":"10_CR131","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/0277-5379(93)90006-Q","volume":"19","author":"T Philip","year":"1983","unstructured":"Philip T, Biron P, Herve P, Dutou L, Ehrsam A, Philip I, Souillet G, Plouvier E, Le Mevel A, Philippe N, Vuvan O, Bouffet E, Bachmann P, Cordier JF, Freycon F, Brunat-Mentigny M (1983). Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin\u2019s malignant lymphoma with a very bad prognosis. Eur J Cancer Clin Oncol 19:1371.","journal-title":"Eur J Cancer Clin Oncol"},{"key":"10_CR132","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1992.10.11.1690","volume":"10","author":"R Chopra","year":"1992","unstructured":"Chopra R, Goldstone AH, Pearce R, Philip T, Petersen F, Appelbaum F, De Vol E, Ernst P (1992). Autologous versus allogeneic bone marrow transplantation for non-Hodgkin\u2019s lymphoma: a case-controlled analysis of the European Bone Marrow Transplant Group registry data. J Clin Oncol 10:1690.","journal-title":"J Clin Oncol"},{"key":"10_CR133","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1200\/JCO.1986.4.11.1628","volume":"4","author":"CN Coleman","year":"1986","unstructured":"Coleman CN, Picozzi VJ, Cox RS, McWirter K, Weiss LM, Cohen JR, Yu KP, Rosenberg SA (1986). Treatment of lymphoblastic lymphoma in adults. J Clin Oncol 4:1628.","journal-title":"J Clin Oncol"},{"key":"10_CR134","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2141.1992.tb06423.x","volume":"82","author":"OB Eden","year":"1992","unstructured":"Eden OB, Hann I, Imeson J, Cotterill S, Gerrard M, Pinkerton CR (1992). Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children\u2019s Cancer Study Group (UKCCSG) protocol 8503. Br J Haematol 82:310.","journal-title":"Br J Haematol"},{"key":"10_CR135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/oxfordjournals.annonc.a057692","volume":"1","author":"C Bernasconi","year":"1990","unstructured":"Bernasconi C, Brusamolino E, Lazzarino M, Morra E, Pagnucco G, Orlandi E (1990). Lymphoblastic lymphoma in adult patients: clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemia. Ann Oncol 1:141.","journal-title":"Ann Oncol"},{"key":"10_CR136","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1992.10.7.1078","volume":"10","author":"P Morel","year":"1992","unstructured":"Morel P, Lepage E, Brice P, Dupriez B, D\u2019Agay M-F, Fenaux P, Gosselin B, Bauters F, Gisselbrecht C (1992). Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients. J Clin Oncol 10:1078.","journal-title":"J Clin Oncol"},{"key":"10_CR137","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/oxfordjournals.annonc.a058157","volume":"3","author":"JA Spinolo","year":"1992","unstructured":"Spinolo JA, Cabanillas F, Dixon DO, Khorana SM, McLaughlin P, Velasquez WS, Hagemeister FB, Redman JR, Swan F Jr (1992). Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure. Ann Oncol 3:227.","journal-title":"Ann Oncol"},{"key":"10_CR138","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.1992.10.6.942","volume":"10","author":"DJ Weisdorf","year":"1992","unstructured":"Weisdorf DJ, Andersen JW, Glick JH, Oken MM (1992). Survival after relapse of low-grade non-Hodgkin\u2019s lymphoma: implications for marrow transplantation. J Clin Oncol 10:942.","journal-title":"J Clin Oncol"},{"key":"10_CR139","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1182\/blood.V77.11.2524.2524","volume":"77","author":"AS Freedman","year":"1991","unstructured":"Freedman AS, Ritz J, Neuberg D, Anderson KC, Rabinowe SN, Mauch P, Takvorian T, Soiffer R, Blake K, Yeap B, Coral F, Nadler LM (1991). Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin\u2019s lymphoma. Blood 77:2524.","journal-title":"Blood"},{"key":"10_CR140","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1994.12.6.1177","volume":"12","author":"AZS Rohatiner","year":"1994","unstructured":"Rohatiner AZS, Johnson PWM, Price CGA, Arnott SJ, Amess JAL, Norton AJ, Dorey E, Adams K, Whelan JS, Matthews J, MacCallum PK, Oza AM, Lister TA (1994). Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma. J Clin Oncol 12:1177.","journal-title":"J Clin Oncol"},{"key":"10_CR141","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1200\/JCO.1993.11.10.1841","volume":"11","author":"AS Freedman","year":"1976","unstructured":"Freedman AS, Nadler LM (1993). Which patients with relapsed non-Hodgkin\u2019s lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation. J Clin Oncol 11:1841.","journal-title":"J Clin Oncol"},{"key":"10_CR142","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1200\/JCO.1995.13.1.140","volume":"13","author":"PWM Johnson","year":"1995","unstructured":"Johnson PWM, Rohatiner AZS, Whelan JS, Price CGA, Love S, Lim J, Matthews J, Norton AJ, Amess JAL, Lister TA (1995). Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol 13:140.","journal-title":"J Clin Oncol"},{"issue":"SI","key":"10_CR143","first-page":"206a","volume":"84","author":"IF Khouri","year":"1994","unstructured":"Khouri IF, Suki S, van Besien K, McLaughlin P, Vriesendorp H, Przepiorka D, Andersson B, Giralt S, Gajewski J, Mehra R, Cabanillas F, Deisseroth AB, Champlin RE (1994). Etoposide, cyclophosphamide, total body irradiation and autologous bone marrow transplantation for low grade non-Hodgkin\u2019s lymphoma. Blood 84 SI:206a (abstract).","journal-title":"Blood"},{"key":"10_CR144","doi-asserted-by":"crossref","unstructured":"144. Van Besien KW, Khouri IF, Giralt SA, McCarthy P, Mehra R, Andersson B, Przepiorka D, Gajewski JL, Bellare N, Nath R, Romaguera J, McLaughlin P, Korbling M, Deisseroth AB, Cabanillas F, Champlin RE (in press). Allogeneic bone marrow transplantation for refractory and recurrent low grade lymphoma\u2014the case for aggressive management. J Clin Oncol.","DOI":"10.1200\/JCO.1995.13.5.1096"},{"key":"10_CR145","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199111283252201","volume":"325","author":"JG Gribben","year":"1991","unstructured":"Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM (1991). Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525.","journal-title":"N Engl J Med"},{"key":"10_CR146","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1182\/blood.V83.12.3800.3800","volume":"83","author":"JG Gribben","year":"1994","unstructured":"Gribben JG, Neuberg D, Barber M, Moore J, Pesek KW, Freedman AS, Nadler LM (1994). Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood 83:3800.","journal-title":"Blood"},{"key":"10_CR147","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1200\/JCO.1994.12.4.798","volume":"12","author":"PWM Johnson","year":"1994","unstructured":"Johnson PWM, Price CGA, Smith T, Cotter FE, Meerabux J, Rohatiner AZS, Young BD, Lister TA (1994). Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 12:798.","journal-title":"J Clin Oncol"},{"key":"10_CR148","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1182\/blood.V69.3.929.929","volume":"69","author":"JS Lee","year":"1987","unstructured":"Lee JS, Dixon DO, Kantarjian HM, Keating MJ, Talpaz M (1987). Prognosis of chronic lymphocytic leukemia: a multivariate regression analysis of 325 untreated patients. Blood 69:929.","journal-title":"Blood"},{"key":"10_CR149","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1200\/JCO.1994.12.4.748","volume":"12","author":"IF Khouri","year":"1994","unstructured":"Khouri IF, Keating MJ, Vriesendorp HM, Reading CL, Przepiorka D, Huh YO, Andersson B, Van Besien KW, Mehra RC, Giralt SA, Ippoliti C, Marshall M, Thomas MW, O\u2019Brien S, Robertson LE, Deisseroth AB, Champlin RE (1994). Autologous and allogeneic bone marrow transplantation for chronic lymphocytic leukemia. J Clin Oncol 12:748.","journal-title":"J Clin Oncol"},{"key":"10_CR150","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1182\/blood.V82.4.1366.1366","volume":"82","author":"SN Rabinowe","year":"1993","unstructured":"Rabinowe SN, Soiffer RJ, Gribben JG, Daley H, Freedman AS, Daley J, Pesek K, Neuberg D, Pinkus G, Leavitt PR, Spector NA, Grossbard ML, Anderson K, Robertson MJ, Mauch P, Chayt-Marcus K, Ritz J, Nadler LM (1993). Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemia. Blood 82:1366.","journal-title":"Blood"},{"key":"10_CR151","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1182\/blood.V83.5.1193.1193","volume":"83","author":"DE Reece","year":"1994","unstructured":"Reece DE, Connors JM, Spinelli JJ, Barnett MJ, Fairey RN, Klingemann H, Nantel SH, O\u2019Reilly S, Shepherd JD, Sutherland HJ, Voss N, Chan K, Phillips GL (1994). Intensive therapy with cyclophosphamide, carmustine, etoposide \u00b1 cisplatin, and autologous bone marrow transplantation for Hodgkin\u2019s disease in first relapse after combination chemotherapy. Blood 83:1193.","journal-title":"Blood"},{"key":"10_CR152","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.1990.8.4.648","volume":"8","author":"C Wheeler","year":"1990","unstructured":"Wheeler C, Antin JH, Churchill WH, Come SE, Smith BR, Bubley GJ, Rosenthal DS, Rappaport JM, Ault KA, Schnipper LE, Eder JP (1990). Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma: a dose-finding study. J Clin Oncol 8:648.","journal-title":"J Clin Oncol"},{"key":"10_CR153","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1182\/blood.V77.11.2322.bloodjournal77112322","volume":"77","author":"A Kessinger","year":"1991","unstructured":"Kessinger A, Bierman PJ, Vose JM, Armitage JO (1991). High-dose cyclophosphamide, carmustine, and etoposide followed by autologous peripheral stem cell transplantation for patients with relapsed Hodgkin\u2019s disease. Blood 77:2322.","journal-title":"Blood"},{"key":"10_CR154","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1200\/JCO.1989.7.2.179","volume":"7","author":"S Jagannath","year":"1989","unstructured":"Jagannath S, Armitage JO, Dicke KA, Tucker SL, Velasquez WS, Smith K, Vaughan WP, Kessinger A, Horwitz LJ, Hagemeister FB, McLaughlin P, Cabanillas F, Spitzer G (1989). Prognostic factors for response and survival after high-dose cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation for relapsed Hodgkin\u2019s disease. J Clin Oncol 7:179.","journal-title":"J Clin Oncol"},{"key":"10_CR155","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood.V81.5.1137.1137","volume":"81","author":"R Chopra","year":"1993","unstructured":"Chopra R, McMillan AK, Linch DC, Yuklea S, Taghipour G, Pearce R, Patterson KG, Goldstone AH (1993). The place of high-dose BEAM therapy and autologous bone marrow transplantation in poor-risk Hodgkin\u2019s disease. A single-center eight-year study of 155 patients. Blood 81:1137.","journal-title":"Blood"},{"key":"10_CR156","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1200\/JCO.1993.11.12.2342","volume":"11","author":"JE Anderson","year":"1993","unstructured":"Anderson JE, Litzow MR, Appelbaum FR, Schoch G, Fisher LD, Buckner CD, Petersen FB, Crawford SW, Press OW, Sanders JE, Bensinger WI, Martin PJ, Storb R, Sullivan KM, Hansen JA, Thomas ED (1993). Allogeneic, syngeneic, and autologous bone marrow transplantation for Hodgkin\u2019s disease: the 21 year Seattle experience. J Clin Oncol 11: 2342.","journal-title":"J Clin Oncol"},{"key":"10_CR157","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1200\/JCO.1993.11.6.1062","volume":"11","author":"J Yahalom","year":"1993","unstructured":"Yahalom J, Gulati SC, Toia M, Maslak P, McCarron EG, O\u2019Brien JP, Portlock CS, Straus DJ, Phillips J, Fuks Z (1993). Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin\u2019s disease. J Clin Oncol 11:1062.","journal-title":"J Clin Oncol"},{"key":"10_CR158","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.1990.8.3.527","volume":"8","author":"RJ Jones","year":"1990","unstructured":"Jones RJ, Piantadosi S, Mann RB, Ambinder RF, Seifter EJ, Vriesendorp HM, Abeloff MD, Burns WH, May WS, Rowley SD, Vogelsang GB, Wagner JE, Wiley JM, Wingard JR, Yeager AM, Sarai R, Santos GW (1990). High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin\u2019s disease. J Clin Oncol 8:527.","journal-title":"J Clin Oncol"},{"key":"10_CR159","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1182\/blood.V83.5.1161.1161","volume":"83","author":"PJ Bierman","year":"1994","unstructured":"Bierman PJ, Vose JM, Armitage JO (1994). Autologous bone marrow transplantation for Hodgkin\u2019s disease: coming of age? Blood 83:1161.","journal-title":"Blood"},{"key":"10_CR160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/oxfordjournals.annonc.a057689","volume":"1","author":"S Viviani","year":"1990","unstructured":"Viviani S, Negretti E, Bonfante V, Valagussa P, Bonadonna G (1990). Salvage chemotherapy in Hodgkin\u2019s disease. Ann Oncol 1:123.","journal-title":"Ann Oncol"},{"key":"10_CR161","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/oxfordjournals.annonc.a058043","volume":"2","author":"AM Gianni","year":"1991","unstructured":"Gianni AM, Siena S, Bregni M, Lombardi F, Gandola L, Valagussa P, Bonnadonna G (1991). Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haematopoietic autologous transplantation in poor prognosis Hodgkin\u2019s disease. Ann Oncol 2:645.","journal-title":"Ann Oncol"},{"key":"10_CR162","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.1992.10.2.200","volume":"10","author":"CE Desch","year":"1992","unstructured":"Desch CE, Lasala MR, Smith TJ, Hillner BE (1992). The optimal timing of autologous bone marrow transplantation in Hodgkin\u2019s disease patients after a chemotherapy relapse. J Clin Oncol 10:200.","journal-title":"J Clin Oncol"},{"key":"10_CR163","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.1992.10.2.175","volume":"10","author":"GP Canellos","year":"1992","unstructured":"Canellos GP (1992). The second chance for advanced Hodgkin\u2019s disease. J Clin Oncol 10:175.","journal-title":"J Clin Oncol"},{"key":"10_CR164","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/0140-6736(93)92411-L","volume":"341","author":"DC Linch","year":"1993","unstructured":"Linch DC, Winfield D, Goldstone AH, Moir D, Hancock B, McMillan A, Chopra R, Milligan D, Hudson CV (1993). Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin\u2019s disease: results of a BNLI randomised trial. Lancet 341:1051.","journal-title":"Lancet"},{"key":"10_CR165","first-page":"99","volume":"8","author":"AM Carella","year":"1991","unstructured":"Carella AM, Carlier P, Congiu A, Occhini D, Nati S, Santini G, Pierluigi D, Giordano D, Bacigalupo A, Damasio E (1991). Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin\u2019s disease in first complete remission after MOPP\/ABVD protocol. Bone Marrow Transplant 8:99.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR166","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1200\/JCO.1993.11.6.1132","volume":"11","author":"WP Peters","year":"1993","unstructured":"Peters WP, Ross M, Vredenburgh JJ, Meisenberg B, Marks LB, Winer E, Kurtzberg J, Bast RC Jr, Jones R, Shpall E, Wu K, Rosner G, Gilbert C, Mathias B, Coniglio D, Petros W, Henderson IC, Norton L, Weiss RB, Budman D, Hurd D (1993). High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 11:1132.","journal-title":"J Clin Oncol"},{"key":"10_CR167","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.V80.7.1666.1666","volume":"80","author":"S Jagannath","year":"1992","unstructured":"Jagannath S, Vesole DH, Glenn L, Crowley J, Barlogie B (1992). Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 80:1666.","journal-title":"Blood"},{"key":"10_CR168","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood.V81.10.2579.2579","volume":"81","author":"W Brugger","year":"1993","unstructured":"Brugger W, M\u00f6cklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L (1993). Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-l\u00df (IL-l\u00df), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood 81: 2579.","journal-title":"Blood"},{"key":"10_CR169","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V82.2.378.378","volume":"82","author":"MR Koller","year":"1993","unstructured":"Koller MR, Emerson SG, Palsson BO (1993). Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82:378.","journal-title":"Blood"},{"key":"10_CR170","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM199308123290703","volume":"329","author":"MS Kaminski","year":"1993","unstructured":"Kaminski MS, Zasadny KR, Francis IR, Milik AW, Ross CW, Moon SD, Crawford SM, Burgess JM, Petry NA, Butchko GM, Glenn SD, Wahl RL (1993). Radioimmunotherapy of B-cell lymphoma with [13lI]anti-Bl (anti-CD20) antibody. N Engl J Med 329:459.","journal-title":"N Engl J Med"},{"key":"10_CR171","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1056\/NEJM199310213291702","volume":"329","author":"OW Press","year":"1993","unstructured":"Press OW, Eary JF, Appelbaum FR, Martin PJ, Badger CC, Nelp WB, Glenn S, Butchko G, Fisher D, Porter B, Matthews DC, Fisher LD, Bernstein ID (1993). Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 329: 1219.","journal-title":"N Engl J Med"},{"key":"10_CR172","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0167-5699(93)90041-I","volume":"14","author":"ES Vitetta","year":"1993","unstructured":"Vitetta ES, Thorpe PE, Uhr JW (1993). Immunotoxins: magic bullets or misguided missiles. Immunol Today 14:252.","journal-title":"Immunol Today"},{"key":"10_CR173","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0198-8859(92)90115-4","volume":"34","author":"AD Hess","year":"1992","unstructured":"Hess AD, Jones RJ, Morris LE, Noga SJ, Vogelsang GB, Santos GW (1992). Autologous graft-versus-host disease: a novel approach for antitumor immunotherapy. Hum Immunol 34:219.","journal-title":"Hum Immunol"},{"key":"10_CR174","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1182\/blood.V83.12.3437.3437","volume":"83","author":"RM Stone","year":"1994","unstructured":"Stone RM (1994). Myelodysplastic syndrome after autologous bone marrow transplantation for lymphoma: the price of progress? Blood 83:3437.","journal-title":"Blood"},{"key":"10_CR175","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V83.12.3780.3780","volume":"83","author":"JS Miller","year":"1994","unstructured":"Miller JS, Arthur DC, Litz CE, Neglia JP, Miller WJ, Weisdorf DJ (1994). Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 83:3780.","journal-title":"Blood"},{"key":"10_CR176","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1200\/JCO.1994.12.12.2535","volume":"12","author":"RM Stone","year":"1994","unstructured":"Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN, Aster JC, Leavitt P, Mauch P, Freedman AS, Nadler LM (1994). Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin\u2019s lymphoma. J Clin Oncol 12:2535.","journal-title":"J Clin Oncol"},{"key":"10_CR177","first-page":"105","volume":"3","author":"G Michel","year":"1988","unstructured":"Michel G, Maraninchi D, Demeocq F, Perrimond H, Blaise D, Gaspard MH, Stoppa AM, Gastaut JA, Lepeu G, Novakovitch G, Marguerite G, Carcassonne Y (1988). Repeated courses of high dose melphalan and unpurged autologous bone marrow transplantation in children with acute non-lymphoblastic leukemia in first complete remission. Bone Marrow Transplant 3:105.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR178","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2141.1986.tb07522.x","volume":"63","author":"JY Cahn","year":"1986","unstructured":"Cahn JY, Herve P, Flesch M, Plouvier E, Noir A, Racadot E, Montcuquet P, Behar C, Pignon B, Boilletot A, Lutz P, Henon P, Rozenbaum A, Peters A, Leconte des Floris R (1986). Autologous bone marrow transplantation (ABMT) for acute leukemia in complete remission: a pilot study of 33 cases. Br J Hematol 63:457.","journal-title":"Br J Hematol"},{"key":"10_CR179","first-page":"425","volume":"6","author":"C Lenarsky","year":"1990","unstructured":"Lenarsky C, Weinberg K, Petersen J, Nolta J, Brooks J, Annett G, Kohn D, Parkman R (1990). Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purged marrow for children with acute non-lymphoblastic leukemia in second remission. Bone Marrow Transplant 6:425.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR180","first-page":"1199","volume":"75","author":"ED Ball","year":"1990","unstructured":"Ball ED, Mills LE, Cornwell GG, III, Davis BH, Coughlin CT, Howell AL, Stukel TA, Dain BJ, McMillan R, Spruce W, Miller WE, Thompson L (1990). Autologous bone marrow transplantation for acute myeloid leukemia using monoclonal antibody-purged bone marrow. Blood 75:1199.","journal-title":"Blood"},{"key":"10_CR181","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood.V74.5.1507.1507","volume":"74","author":"DW Beelen","year":"1989","unstructured":"Beelen DW, Quabeck K, Graeven U, Sayer HG, Mahmoud HK, Schaefer UW (1989). Acute toxicity and first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia. Blood 74:1507.","journal-title":"Blood"},{"key":"10_CR182","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM198607173150301","volume":"315","author":"AM Yeager","year":"1986","unstructured":"Yeager AM, Kaizer H, Santos GW, Sarai R, Colvin OM, Stuart RK, Braine HG, Burke PJ, Ambinder RF, Burns WH, Fuller DJ, Davis JM, Sensenbrenner LL, Vogelsang GB, Wingard JR (1986). Autologous bone marrow tranplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N Engl J Med 315:141.","journal-title":"N Engl J Med"},{"key":"10_CR183","first-page":"267","volume":"13","author":"P Stewart","year":"1985","unstructured":"Stewart P, Buckner CD, Bensinger W, Appelbaum F, Fefer A, Clift R, Storb R, Sanders J, Meyers J, Hill R, Thomas ED (1985). Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission. Exp Hematol 13:267.","journal-title":"Exp Hematol"},{"key":"10_CR184","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(86)90828-7","volume":"1","author":"J Chang","year":"1986","unstructured":"Chang J, Coutino L, Morgenstern G, Scarffe JH, Deakin D, Harrison C, Testa NG, Dexter TM (1986). Reconstitution of hemopoietic system with autologous marrow taken during relapse of acute myeloblastic leukemia and grown in long term culture. Lancet 1:294.","journal-title":"Lancet"},{"key":"10_CR185","first-page":"699","volume":"33","author":"H Koeppler","year":"1990","unstructured":"Koeppler H, Pflueger KH, Wolf M, Weide R, Havemann K (1990). High-dose chemotherapy with noncryopreserved autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. Haematol Blood Transfusion 33:699.","journal-title":"Haematol Blood Transfusion"},{"issue":"S1","key":"10_CR186","first-page":"507a","volume":"78","author":"H Solh","year":"1991","unstructured":"Solh H, Saunders EF, Freedman M (1991). Autologous bone marrow transplantation following high-dose busulfan and cyclophophamide using unpurged marrow in children with acute nonlymphoblastic leukemia. Blood 78 S1:507a.","journal-title":"Blood"},{"key":"10_CR187","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0140-6736(84)92094-4","volume":"ii","author":"B L\u00f6wenberg","year":"1984","unstructured":"L\u00f6wenberg B, Hagenbeek A, Sizoo W, de Gast GC, Verdonck LF (1984). Bone marrow transplantation strategies in acute leukemia. Lancet ii:1400.","journal-title":"Lancet"},{"key":"10_CR188","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1200\/JCO.1994.12.10.2138","volume":"12","author":"JP Shaw","year":"1994","unstructured":"Shaw JP, Bergin ME, Burgess MA, Dalla Pozza L, Kellie SJ, Rowell G, Stevens MM, Webster BH, Bradstock KF (1994). Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan\/cyclophosphamide for bone marrow transplantation. J Clin Oncol 12:2138.","journal-title":"J Clin Oncol"},{"key":"10_CR189","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1056\/NEJM199501263320403","volume":"332","author":"RA Zittoun","year":"1995","unstructured":"Zittoun RA, Mandelli F, Willemze R, de Witte T, Labar B, Resegotti L, Leoni F, Damasio E, Visani G, Papa G, Caronia F, Hayat M, Stryckmans P, Rotoli B, Leoni P, Peetermans ME, Dardenne M, Vegna ML, Petti MC, Solbu G, Suciu S, for the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne Dell\u2019Adulto (GIMEMA) Leukemia Cooperative Groups (1995). Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 332:217.","journal-title":"N Engl J Med"},{"key":"10_CR190","first-page":"315","volume":"12","author":"K Doney","year":"1993","unstructured":"Doney K, Buckner CD, Fisher L, Petersen FB, Sanders J, Appelbaum FR, Anasetti C, Badger C, Bensinger W, Deeg HJ, Fefer A, Martin P, Petersdorf E, Schuening F, Singer J, Stewart P, Storb R, Sullivan KM, Witherspoon R, Hansen JA (1993). Autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 12:315.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR191","first-page":"7","volume":"5","author":"D Blaise","year":"1990","unstructured":"Blaise D, Gaspard MH, Stoppa AM, Michel G, Gastaut JA, Lepeu G, Tubiana N, Blanc AP, Rossi JF, Novakovitch G, Mannoni P, Mawas C, Maraninchi D, Carcassonne Y (1990). Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission. Bone Marrow Transplant 5:7.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR192","first-page":"1289","volume":"76","author":"JL Pico","year":"1986","unstructured":"Pico JL, Hartmann O, Maraninchi D, Beaujean F, Benhamou E, Mascret B, Novakovitch G, Ghalie R, Kalifa C, Hayat M, Patte C, Carcassone Y, Lemerle J (1986). Modified chemotherapy with carmustine, cytarabine, cyclophosphamide and 6-thioguanine (BACT) and autologous bone marrow transplantation in 24 poor risk patients with acute lymphoblastic leukemia. J Natl Cancer Inst 76:1289.","journal-title":"J Natl Cancer Inst"},{"key":"10_CR193","first-page":"243","volume":"12","author":"RJ Soiffer","year":"1993","unstructured":"Soiffer RJ, Roy DC, Gonin R, Murray C, Anderson KC, Freedman AS, Rabinowe SN, Robertson MJ, Spector N, Pesek K, Mauch P, Nadler LM, Ritz J (1993). Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse. Bone Marrow Transplant 12:243.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR194","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood.V81.6.1651.1651","volume":"81","author":"AL Billett","year":"1993","unstructured":"Billett AL, Kornmehl E, Tarbell NJ, Weinstein HJ, Gelber RD, Ritz J, Sallan SE (1993). Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia. Blood 81:1651.","journal-title":"Blood"},{"key":"10_CR195","first-page":"692","volume":"33","author":"F Zintl","year":"1990","unstructured":"Zintl F, Hermann J, Fuchs D, Prager J, Reiners B, M\u00fcller A, Kob D, Goetz I, Metzner G (1990). Comparison of allogeneic and autologous bone marrow transplantation for treatment of acute lymphocytic leukemia in childhood. Haematol Blood Transfusion 33:692.","journal-title":"Haematol Blood Transfusion"},{"key":"10_CR196","first-page":"S:28","volume":"8","author":"P Herv\u00e9","year":"1991","unstructured":"Herv\u00e9 P, Labopin M, Plouvier E, Palut P, Tiberghien P, Gorin NC, EBMT Working Party on ABMT (1991). Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia\u2014a European survey. Bone Marrow Transplant 8 S:72.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR197","first-page":"S3:28","volume":"7","author":"P Colleselli","year":"1991","unstructured":"Colleselli P, Dini G, Andolina M, Bonetti F, Miniero R, Sonego M, Pigozzo P, Messina C, Porta F, Sotti G, Zanesco L (1991). Autologous bone marrow transplantation for acute lymphoblastic leukemia: the high dose vincristine study of AIEOP BMT group. Bone Marrow Transplant 7 S3:28.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR198","first-page":"1","volume":"7","author":"JY Cahn","year":"1991","unstructured":"Cahn JY, Bordigoni P, Souillet G, Pico JL, Plouvier E, Reiffers J, Benz-Lemoine E, Bergerat JP, Lutz P, Colombat P, Herve P (1991). The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients. Bone Marrow Transplant 7:1.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR199","first-page":"247","volume":"6","author":"P Fabritiis De","year":"1990","unstructured":"De Fabritiis P, Sandrelli A, Meloni G, Alimena G, Montefusco E, Lo Coco F, De Felice L, Mandelli F (1990). Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting. Bone Marrow Transplant 6:247.","journal-title":"Bone Marrow Transplant"},{"issue":"S1","key":"10_CR200","first-page":"537a","volume":"84","author":"P McGlave","year":"1994","unstructured":"McGlave P, Miller W, Perry E, Fautsch S, Ramsay NKC, Verfaillie CM, Weisdorf D (1994). Autologous marrow transplant therapy for CML using marrow treated ex vivo with human recombinant interferon gamma. Blood 84 S1:537a (abstract).","journal-title":"Blood"},{"key":"10_CR201","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ajh.2830180304","volume":"18","author":"DD Karp","year":"1985","unstructured":"Karp DD, Parker LM, Binder M, Tantravahi R, Smith BR, Ervin TJ, Canellos GP (1985). Treatment of the blastic transformation of chronic granulocytic leukemia using high dose BCNU chemotherapy and cryopreserved autologous peripheral blood stem cells. Am J Hematol 18:243.","journal-title":"Am J Hematol"},{"key":"10_CR202","first-page":"1351","volume":"68","author":"HD Preisler","year":"1984","unstructured":"Preisler HD, Raza A, Higby D, Kirshner J, Woll J, Bennett J, Winton L, Weiner R, Richman C, Golomb H, Goldberg J (1984). Treatment of myeloid blastic crisis of chronic myelogenous leukemia. Cancer Treatment Rep 68:1351.","journal-title":"Cancer Treatment Rep"},{"key":"10_CR203","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/0002-9343(83)90893-8","volume":"75","author":"WR Vogler","year":"1983","unstructured":"Vogler WR, Winton EF, James S, O\u2019Neill S, Granade S, Mallard G (1983). Autologous marrow transplantation after karyotypic conversion to normal in blastic phase of chronic myelocytic leukemia. Am J Med 75:1080.","journal-title":"Am J Med"},{"key":"10_CR204","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ajh.2830160202","volume":"16","author":"MR Thomas","year":"1984","unstructured":"Thomas MR, Robinson WA, Dantas M, Koeppler H, Drebing C, Globe LM (1984). Autologous marrow transplantation for patients with chronic myelogenous leukemia in blast crisis. Am J Hematol 16:105.","journal-title":"Am J Hematol"},{"key":"10_CR205","first-page":"105","volume":"14","author":"MP Lemonnier","year":"1986","unstructured":"Lemonnier MP, Gorin NC, Laporte JP, et al. (1986). Autologous marrow transplantation for patients with chronic myeloid leukemia in accelerated or blastic phase: report of 14 cases. Exp Hematol 14:105.","journal-title":"Exp Hematol"},{"key":"10_CR206","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198406143102403","volume":"310","author":"GL Phillips","year":"1984","unstructured":"Phillips GL, Herzig RH, Lazarus HM, et al. (1984). Treatment of resistant malignant lymphoma with cyclophospamide, total body irradiation and transplantation of cryoperserved autologous marrow. N Engl J Med 310:1557 (abstract).","journal-title":"N Engl J Med"},{"key":"10_CR207","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/1097-0142(19910615)67:12<2959::AID-CNCR2820671203>3.0.CO;2-T","volume":"67","author":"HM Kantarjian","year":"1991","unstructured":"Kantarjian HM, Talpaz M, LeMaistre CF, Spinolo J, Spitzer G, Yau J, Dicke K, Jagannath S, Deisseroth AB (1991). Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome-negative cells in chronic myelogenous leukemia. Cancer 67:2959.","journal-title":"Cancer"},{"key":"10_CR208","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1365-2141.1984.tb06118.x","volume":"58","author":"ME Haines","year":"1984","unstructured":"Haines ME, Goldman JM, Worsley AM, et al. (1984). Chemotherapy and autografting for chronic granulocytic leukemia in transformation: probable prolongation of survival for some patients. Br J Haematol 58:711.","journal-title":"Br J Haematol"},{"key":"10_CR209","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/0959-8049(92)90235-T","volume":"28A","author":"T Philip","year":"1992","unstructured":"Philip T, Meckenstock R, Deconnick E, Carrie C, Bailly C, Colombat P, Dauriac C, Demaille MC, Salles B, Cahn JY, Turpin F, Biron P (1992). Treatment of poor prognosis Burkitt\u2019s lymphoma in adults with the societe Francaise d\u2019oncologie pediatrique LMB protocol\u2014a study of the federation nationale de centres de lutte contre le cancer (FNLCC). Eur J Cancer 28A:1954.","journal-title":"Eur J Cancer"},{"key":"10_CR210","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/BF00273421","volume":"22","author":"MH Gaspard","year":"1988","unstructured":"Gaspard MH, Maraninchi D, Stoppa AM, Gastaut JA, Michel G, Tubiana N, Blaise D, Novakovitch G, Rossi JF, Weiller PJ, Sainty D, Horchowski N, Carcassonne Y (1988). Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor risk malignancies. Cancer Chemother Pharmacol 22:256.","journal-title":"Cancer Chemother Pharmacol"},{"key":"10_CR211","doi-asserted-by":"crossref","first-page":"10559","DOI":"10.1002\/1097-0142(197803)41:3<1059::AID-CNCR2820410339>3.0.CO;2-N","volume":"41","author":"FR Appelbaum","year":"1978","unstructured":"Appelbaum FR, Deisseroth AB, Graw RG, Herzig GP, Levine AS, Magrath IT, Pizzo PA, Poplack DG, Ziegler JL (1978). Prolonged complete remission following high dose chemotherapy of Burkitt\u2019s lymphoma in relapse. Cancer 41:10559.","journal-title":"Cancer"},{"key":"10_CR212","first-page":"373","volume":"1","author":"WP Vaughan","year":"1987","unstructured":"Vaughan WP, Weisenburger DD, Sanger W, Gale RP, Armitage JO (1987). Early leukemic recurrence of non-Hodgkin lymphoma after high-dose anti-neoplastic therapy with autologous marrow rescue. Bone Marrow Transplant 1:373.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR213","first-page":"389","volume":"34","author":"M Ostronoff","year":"1992","unstructured":"Ostronoff M, Soussain C, Zambon E, Ibrahim A, Bosq J, Bayle C, Pico JL, Gilles E, Moran A, Droz JP, Patte C, Hayat M (1992). Burkitt\u2019s lymphoma in adults: a retrospective study of 46 cases. Nouv Rev Fr Hematol 34:389.","journal-title":"Nouv Rev Fr Hematol"},{"key":"10_CR214","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1200\/JCO.1984.2.9.979","volume":"2","author":"O Hartmann","year":"1984","unstructured":"Hartmann O, Pein F, Beaujean F, Kalifa C, Patte C, Parmentier C, Lemerle J (1984). High-dose polychemotherapy with autologous bone marrow transplantation in children with relapsed lymphomas. J Clin Oncol 2:979.","journal-title":"J Clin Oncol"},{"key":"10_CR215","first-page":"465","volume":"8","author":"HA Loiseau","year":"1991","unstructured":"Avet Loiseau H, Hartmann O, Valteau D, McDowell H, Brugieres L, Vassal G, Kalifa C, Patte C, Lemerle J (1991). High-dose chemotherapy containing busulfan followed by bone marrow transplantation in 24 children with refractory or relapsed non-Hodgkin\u2019s lymphoma. Bone Marrow Transplant 8:465.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR216","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0002-9343(91)90573-G","volume":"90","author":"DJ Straus","year":"1991","unstructured":"Straus DJ, Wong GY, Liu J, Oppenberg J, Filippa DA, Gold JWM, Offit K, Clarkson BD (1991). Small non-cleaved-cell lymphoma (undifferentiated lymphoma, Burkitt\u2019s type) in American adults: results with treatment designed for acute lymphoblastic leukemia. Am J Med 90:328.","journal-title":"Am J Med"},{"issue":"Suppl 5","key":"10_CR217","first-page":"309","volume":"7","author":"H Kaizer","year":"1979","unstructured":"Kaizer H, Wharam MD, Munoz LL, Johnson RJ, Elfenbein GJ, Tutschka PJ, Braine HG, Santos GW, Leventhal BG (1979). Autologous bone marrow transplantation in the treatment of selected human malignancies: the Johns Hopkins oncology center program. Exp Hematol 7 (Suppl 5):309.","journal-title":"Exp Hematol"},{"key":"10_CR218","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.1994.12.7.1358","volume":"12","author":"JW Sweetenham","year":"1994","unstructured":"Sweetenham JW, Liberti G, Pearce R, Taghipour G, Santini G, Goldstone A (1994). High-dose therapy and autologous bone marrow transplantation for adult patients with lymphoblastic lymphoma: results of the European group for bone marrow transplantation. J Clin Oncol 12:1358.","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10_CR219","first-page":"42","volume":"5","author":"G Santini","year":"1991","unstructured":"Santini G, Congiu AM, Coser P, Chisesi T, Porcellini A, Sertoli R, Contu A, Vinante O, Pierluigi D, Vitale V, Rubagotti A, Orcamo P, Rizzoli V (1991). Autologous bone marrow transplantation for adult advanced stage lymphoblastic lymphoma in first CR. A study of the NHLCSG. Leukemia 5 (Suppl 1):42.","journal-title":"Leukemia"},{"key":"10_CR220","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2141.1989.tb00224.x","volume":"73","author":"N Milpied","year":"1989","unstructured":"Milpied N, Ifrah N, Kuentz M, Maraninchi D, Colombat P, Blaise D, Harousseau JL (1989). Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. Br J Haematol 73:82.","journal-title":"Br J Haematol"},{"key":"10_CR221","first-page":"33","volume":"10","author":"J Baro","year":"1992","unstructured":"Baro J, Richard C, Sierra J, Garc\u00eda-Conde J, Garc\u00eda Lara\u00f1a J, Rocha E, Solano C, Caballero D, Carrera D, L\u00e9on A, Zuazu J, Martinez F, Domingo A, Hernandez F, Marin P, Iriondo A, Montserrat E, Conde E (1992). Autologous bone marrow transplantation in 22 adult patients with lymphoblastic lymphoma responsive to conventional dose chemotherapy. Bone Marrow Transplant 10:33.","journal-title":"Bone Marrow Transplant"},{"key":"10_CR222","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1200\/JCO.1992.10.4.644","volume":"10","author":"LF Verdonck","year":"1992","unstructured":"Verdonck LF, Dekker AW, de Gast GC, Lokhorst HM, Nieuwenhuis HK (1992). Autologous bone marrow transplantation for adult poor-risk lymphoblastic lymphoma in first remission. J Clin Oncol 10:644.","journal-title":"J Clin Oncol"},{"key":"10_CR223","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/bjc.1986.127","volume":"53","author":"T Philip","year":"1986","unstructured":"Philip T, Dumont J, Teillet F, et al. (1986). High-dose chemotherapy and autologous bone marrow transplantation in refractory Hodgkin\u2019s disease. Br J Cancer 53:737.","journal-title":"Br J Cancer"},{"key":"10_CR224","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1200\/JCO.1988.6.9.1411","volume":"6","author":"AM Carella","year":"1988","unstructured":"Carella AM, Congiu AM, Gaozza E, Mazza P, Ricci P, Visani G, Meloni G, Cimino G, Mangoni L, Coser P, Cetto GL, Cimino R, Alessandrino EP, Brusamolino E, Santini G, Tura S, Mandelli F, Rizzoli V, Bernasconi C, Marmont A (1988). High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin\u2019s disease patients: an Italian study group report. J Clin Oncol 6:1411.","journal-title":"J Clin Oncol"},{"key":"10_CR225","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0308-2261(86)80009-1","volume":"15","author":"GL Phillips","year":"1986","unstructured":"Phillips GL, Reece DE (1986). Clinical studies of autologous bone marrow transplantation in Hodgkin\u2019s disease. Clin Haematol 15:151.","journal-title":"Clin Haematol"},{"key":"10_CR226","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/mpo.2950180603","volume":"18","author":"DD Hurd","year":"1990","unstructured":"Hurd DD, Haake RJ, Lasky LC, Christiansen NP, McGlave PB, Bostrom B, Levine EG, Weisdorf DJ, Kim TH, Peterson BA, Bloomfield CD (1990). Treatment of refractory and relapsed Hodgkin\u2019s disease: intensive chemotherapy and autologous bone marrow or peripheral stem cell support. Med Pediatr Oncol 18:447.","journal-title":"Med Pediatr Oncol"},{"key":"10_CR227","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1200\/JCO.1991.9.10.1871","volume":"9","author":"DE Reece","year":"1991","unstructured":"Reece DE, Barnett MJ, Connors JM, Fairey RN, Greer JP, Herzig GP, Herzig RH, Klingemann H-G, O\u2019Reilly SE, Shepherd JD, Spinelli JJ, Voss NJ, Wolff SN, Phillips GL (1991). Intensive chemotherapy with cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation for relapsed Hodgkin\u2019s disease. J Clin Oncol 9:1871.","journal-title":"J Clin Oncol"},{"key":"10_CR228","first-page":"86","volume":"457a","author":"C Haioun","year":"1995","unstructured":"Haioun C, Lepage E, Gisselbrecht C, Coiffier B, Bosly A, Dupriez B, Nouvel C, Tilly H, DeconinckLederlin P, Biron P, Bri\u00e8re J, Gaulard Ph, Reyes F (1995). Autologous bone marrow transplantation versu sequential chemotherapy for aggressive non-Hodgkin\u2019s lymphoma in first complete remission: A study of 542 patients (LNH87\u20132 protocol). Blood 86:457a (abstract).","journal-title":"Blood"}],"container-title":["Cancer Treatment and Research","Molecular Genetics and Therapy of Leukemia"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4613-1261-1_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T15:08:08Z","timestamp":1593097688000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4613-1261-1_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"ISBN":["9781461285373","9781461312611"],"references-count":228,"URL":"https:\/\/doi.org\/10.1007\/978-1-4613-1261-1_10","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4613-1261-1","asserted-by":"object"}]},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[1996]]}}}